Chilivis Grubman LLP
  • Home
  • Firm Overview
  • Attorneys
    • Scott R. Grubman
    • Lauren A. Warner
    • Jeremy T. Berry
    • Brittany M. Cambre
    • Joseph J. Siegelman
    • Hakim Hilliard
    • Sanjay Karnik
    • Brandi Z. Murrain
    • Rachel N. Lugay
    • Maiysha Rashad
  • Practice Areas
    • Healthcare
      • Government Investigations & Litigation
      • Payor Audits and Audit Appeals
      • HIPAA and Cybersecurity
      • Medical Board Investigations
      • Peer Review & Credentialing Disputes
      • Healthcare Regulatory Compliance
    • Civil and Business Litigation
      • Class Action Defense
    • Criminal Defense
      • White Collar Crime
      • Healthcare Fraud
      • Public Corruption
      • Internal Investigations
    • False Claims Act and Qui Tam Defense
    • Data Privacy & Cybersecurity
    • Internal Investigations
    • Government Affairs
      • Advocacy and Regulatory Affairs
      • Government Contracts
      • Government Litigation and Administrative Law
      • Advertising Compliance
      • Land Use & Zoning
      • Licensing and Permits
    • Campaign Finance and Election Law
    • Entertainment Law & Artist Management
      • Trademark, Copyright, and Brand Protection
  • Blog
  • News
  • Insights
  • Contact
Select Page

Biogen Inc. Agrees to Pay $900 Million to Settle Allegations Related to Improper Physician Payments

Oct 5, 2022 | Health Care Fraud

On September 26, the Department of Justice (DOJ) announced a Cambridge, MA pharmaceutical company, Biogen Inc. (Biogen), has agreed to pay approximately $900 million to resolve allegations that the company gave doctors kickbacks to encourage them to prescribe Biogen...

Pharmaceutical Giant Biogen Pays Nearly $1 Billion to Resolve False Claims Act Matter

Sep 29, 2022 | False Claims Act, Government Investigations, Health Care Fraud

On September 26, 2022, the Department of Justice (DOJ) announced that pharmaceutical giant Biogen, Inc. agreed to pay $900 million to resolve allegations that it violated the False Claims Act (FCA) by paying prescribing physicians kickbacks in exchange for prescribing...

Bayer Agrees to Pay $40 Million to Resolve the Alleged Use of Kickbacks and False Statements Relating to Three Drugs

Sep 7, 2022 | Health Care Fraud

On September 2, the Department of Justice announced, “Bayer Corporation, an Indiana corporation and manufacturer of pharmaceutical products, and its related entities, Bayer HealthCare Pharmaceuticals Inc., Bayer HealthCare LLC and Bayer AG (collectively “Bayer”), have...

Eleventh Circuit Upholds Convictions of Physician and Nurse Siblings in Healthcare Fraud Trial

Aug 31, 2022 | Health Care Fraud

On August 25, 2022, the Eleventh Circuit upheld the convictions of a former Alabama physician, Patrick Ifediba, and his sister, Ngozi Justina Ozuligbo, who was a nurse who worked at a clinic run by her brother. They were charged and convicted of health care fraud,...

Drug Charges Dropped Against Opioid Manufacturer and Pharmacists After Recent SCOTUS Ruling

Aug 17, 2022 | Health Care, Health Care Fraud

In June 2022, the U.S. Supreme Court issued an opinion in Ruan v. United States that clarified the mens rea requirement for those who manufacture, distribute, or dispense drugs and are subsequently prosecuted under the Controlled Substances Act, specifically 21 U.S.C....

North Carolina Woman Faces up to 120 Years in Prison for Role in $34 Million Health Care Fraud Scheme

Aug 9, 2022 | Health Care, Health Care Fraud

The DOJ just announced the conviction of, Jaroslava Ruiz, for her role in a scheme that defrauded private health insurers of approximately $34.6 million. Ruiz, of Chapel Hill, was convicted of one count of conspiracy to commit health care fraud and wire fraud and 10...
« Older Entries
Next Entries »

Recent Posts

  • The Rebirth of the DOJ’s False Claims Act Working Group
  • When ICE Crosses the Line, What Can Be Done?
  • Chilivis Grubman Secures Important Election Law Victory at Georgia Court of Appeals
  • Medicare Audits: How Long Does Medicare Have to Reopen Claims?
  • Tech Square Phase 3: How Georgia Tech Is Reshaping Midtown Through Strategic Land Use

Categories

  • A.I. Law
  • Accessory Dwelling Units
  • Administrative Law
  • Anti-Counterfeit
  • Brand Protection
  • Business Litigation
  • Civil Healthcare Litigation
  • Civil Matters
  • Civil Rights
  • Code Enforcement
  • Commercial Litigation
  • Commercial Payor Audits
  • Complex Criminal Litigation
  • Copyright Infringement
  • COVID-19 Related Law
  • Criminal Matters
  • Cyber Law
  • Data Breach
  • DMEPOS
  • DOJ
  • Drug Policy Law
  • Election Law
  • Employment Law
  • Environmental
  • False Claims Act
  • federal investigations
  • Federal Tax Investigations
  • FINRA
  • Firm Announcement
  • FOIS Compliance
  • Fraud Investigations
  • General
  • Government Affairs
  • Government Contract
  • Government Investigations
  • Government Litigation
  • Health Care
  • Health Care Fraud
  • Healthcare Transactions
  • HIPAA
  • Housing Development Law
  • Land Use Law
  • Land Zoning Law
  • Liquor Law
  • Medicare and Medicaid
  • Non-Profit Organizations
  • ommercial payor audits
  • Open Records Act
  • Overpayment Appeals
  • PPP Investigations
  • Public Corruption
  • Restrictive Covenants
  • SEC Investigations
  • Special Use Permit Filing
  • State Bar of Georgia Investigations
  • Strategic Land Use
  • Tax Fraud
  • toxic tort
  • Trademark Enforcement
  • Trademark Protection
  • Tree Ordinance
  • Uncategorized
  • Variances
  • White Collar Crime
  • Zoning and Land Use
Built by The Montgomery Group